Amalgamated Bank Haemonetics Corp Transaction History

Amalgamated Bank

$12.6 Billion
Q2 2025

A detailed history of Amalgamated Bank transactions in Haemonetics Corp stock. As of the latest transaction made, Amalgamated Bank holds 22,068 shares of HAE stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,068

Previous 22,402 1.49%

Holding current value

$1.19 Million

Previous $1.42 Million 15.59%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$56.04 - $74.77 $18,717 - $24,973	-334 Reduced 1.49%	22,068 $1.65 Million
Q1 2025 Apr 25, 2025	SELL	$59.34 - $80.05 $34,298 - $46,268	-578 Reduced 2.52%	22,402 $1.42 Million
Q4 2024 Feb 04, 2025	SELL	$71.16 - $93.38 $34,512 - $45,289	-485 Reduced 2.07%	22,980 $1.79 Million
Q3 2024 Oct 30, 2024	SELL	$72.45 - $91.58 $85,853 - $108,522	-1,185 Reduced 4.81%	23,465 $1.89 Million
Q2 2024 Aug 12, 2024	SELL	$81.24 - $97.37 $159,555 - $191,234	-1,964 Reduced 7.38%	24,650 $2.04 Million
Q1 2024 Apr 23, 2024	SELL	$71.24 - $85.35 $392,389 - $470,107	-5,508 Reduced 17.15%	26,614 $2.27 Million
Q4 2023 Feb 06, 2024	SELL	$80.59 - $92.61 $14,425 - $16,577	-179 Reduced 0.55%	32,122 $2.75 Million
Q3 2023 Nov 08, 2023	SELL	$82.56 - $93.49 $53,086 - $60,114	-643 Reduced 1.95%	32,301 $2.89 Million
Q2 2023 Aug 11, 2023	SELL	$80.84 - $89.45 $64,106 - $70,933	-793 Reduced 2.35%	32,944 $2.8 Million
Q1 2023 May 02, 2023	SELL	$72.75 - $90.6 $150,156 - $186,998	-2,064 Reduced 5.77%	33,737 $2.79 Million
Q4 2022 Feb 10, 2023	BUY	$73.85 - $86.14 $16,690 - $19,467	226 Added 0.64%	35,801 $2.82 Million
Q3 2022 Nov 09, 2022	BUY	$63.3 - $78.66 $57,982 - $72,052	916 Added 2.64%	35,575 $2.63 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $35,277 - $47,313	716 Added 2.11%	34,659 $2.26 Million
Q1 2022 Jun 30, 2022	SELL	$43.77 - $63.22 $70,163 - $101,341	-1,603 Reduced 4.51%	33,943 $2.15 Million
Q4 2021 Feb 15, 2022	BUY	$49.55 - $74.59 $10,851 - $16,335	219 Added 0.62%	35,546 $1.89 Million
Q3 2021 Oct 29, 2021	SELL	$57.6 - $70.59 $218,476 - $267,747	-3,793 Reduced 9.7%	35,327 $2.49 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $1.53 Million - $3.5 Million	29,531 Added 307.97%	39,120 $2.61 Million
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $74,376 - $93,451	-670 Reduced 6.53%	9,589 $1.06 Million
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $3,195 - $4,318	36 Added 0.35%	10,259 $1.22 Million
Q3 2020 Oct 30, 2020	SELL	$75.65 - $93.58 $21,408 - $26,483	-283 Reduced 2.69%	10,223 $892,000
Q2 2020 Aug 10, 2020	BUY	$84.96 - $118.91 $75,529 - $105,710	889 Added 9.24%	10,506 $941,000
Q1 2020 May 13, 2020	SELL	$74.34 - $121.82 $39,400 - $64,564	-530 Reduced 5.22%	9,617 $958,000
Q4 2019 Feb 13, 2020	BUY	$114.37 - $129.46 $70,795 - $80,135	619 Added 6.5%	10,147 $1.17 Million
Q3 2019 Nov 13, 2019	SELL	$117.16 - $138.52 $17,105 - $20,223	-146 Reduced 1.51%	9,528 $1.2 Million
Q2 2019 Aug 14, 2019	BUY	$81.74 - $120.34 $113,863 - $167,633	1,393 Added 16.82%	9,674 $1.16 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $13,653 - $16,747	164 Added 2.02%	8,281 $724,000
Q4 2018 Feb 15, 2019	BUY	$90.66 - $116.63 $411,143 - $528,917	4,535 Added 126.61%	8,117 $812,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $465,542 - $592,951	-5,175 Reduced 59.1%	3,582 $410,000
Q2 2018 Jul 18, 2018	BUY	$71.53 - $95.75 $74,820 - $100,154	1,046 Added 13.57%	8,757 $785,000
Q1 2018 May 22, 2018	SELL	$60.72 - $74.41 $2,489 - $3,050	-41 Reduced 0.53%	7,711 $564,000
Q4 2017 Feb 13, 2018	BUY	$44.96 - $58.99 $26,076 - $34,214	580 Added 8.09%	7,752 $450,000
Q3 2017 Nov 09, 2017	BUY	$40.38 - $44.87 $289,605 - $321,807	7,172	7,172 $322,000

Others Institutions Holding HAE

# of Institutions

352

Shares Held

53.2M

Call Options Held

653K

Put Options Held

304K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Haemonetics Corp Transaction History